Chemotherapy Induced Peripheral Neuropathy Treatment Market Projected to Hit $2.25 Billion by 2028
The chemotherapy-induced peripheral neuropathy (CIPN) treatment market is experiencing robust growth, with projections indicating a rise to $2.25 billion by 2028.... Read more.
US FDA Grants Orphan Drug Designation to iOnctura’s Autotaxin Cancer Therapy
iOnctura, a prominent clinical-stage biotechnology company dedicated to advancing revolutionary cancer therapies, has achieved a significant milestone with the recent... Read more.
The Rise of Antimicrobial Resistance: A Growing Public Health Concern
In recent years, the global health community has been sounding the alarm on a looming crisis that threatens to undermine a century of medical progress: the rise... Read more.
Global Liquid Biopsy Market Trends Analysis 2018-2035
The liquid biopsy market is witnessing a significant surge, with the global market size estimated to be $5.4 billion in 2023 and expected to grow at a compound annual... Read more.
Akero’s Fatty Liver Disease Drug Lessens Scarring In Mid-Stage Trial
Akero Therapeutics has reported promising results from its mid-stage trial of an experimental drug for metabolic dysfunction-associated steatohepatitis (MASH), a... Read more.
GSK’s new HIV drug formula could support longer dosing intervals
GSK, a leading pharmaceutical company, announced on Monday the development of a new formulation for its HIV prevention and treatment drug, potentially allowing for... Read more.
Eyenovia’s Eye Drops Secure FDA’s Approval
The U.S. Food and Drug Administration (FDA) has recently granted approval for Eyenovia’s eye drops, aimed at reducing inflammation and pain in patients post-eye... Read more.
Novo Kidney Trial Finds Ozempic Cuts Risk Of Major Cardiac Events and Death By 24%
A recent study conducted by Novo Nordisk, a leading pharmaceutical company, has unveiled promising results regarding the efficacy of their diabetes drug, Ozempic,... Read more.
Allergy Immunotherapy: Exploring the Science Behind a Promising Solution
While allergy immunotherapy is nothing new, it has garnished attention in recent years as a promising solution for those suffering from allergies. This innovative... Read more.
Study Finds Many European Cancer Drugs Provided No Added Benefits
A recent study conducted by researchers at Utrecht University in the Netherlands has shed light on the approval of cancer drugs by the European Medicines Agency... Read more.